Trade Mark Journal No.2025/002 10 January 2025

WO0000001829676 (9,40,42)

Office of origin: United States of America

Date of International Registration:24 September 2024
Date of designation in the UK: 24 September 2024
Image for mark 1829676 HELIANTHOS

International priority date claimed: 26 March 2024 (United States of America) (98468786)
Class 9
Bioreactor system for perfusion fermentation; bioreactor system to continuously process and test parameters and collect data on a range of variables; bioreactor system for continuous protein, molecule, or cell line production using microbes.
Class 40
Manufacturing services for others in the field of biotechnology.
Class 42
Product development; product development in the fields of protein manufacturing; research and development of technology in the field of protein manufacturing; platform as a service services (PaaS) featuring software for designing and developing new products using protein manufacturing; research and development in the biotechnology field.

Sunflower Therapeutics, PBC

Representative: Rachelle A. Dubow, Esq. Morgan, Lewis & Bockius LLP, One Federal Street, Boston MA 02110, UNITED STATES OF AMERICA